SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 157 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $419,000 | -41.8% | 330,052 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $720,000 | -41.8% | 330,052 | 0.0% | 0.00% | -42.9% |
Q2 2021 | $1,238,000 | +26.2% | 330,052 | +9.7% | 0.01% | +16.7% |
Q1 2021 | $981,000 | -10.8% | 300,862 | -6.7% | 0.01% | -25.0% |
Q4 2020 | $1,100,000 | -16.4% | 322,632 | 0.0% | 0.01% | -27.3% |
Q3 2020 | $1,316,000 | +53.9% | 322,632 | +27.5% | 0.01% | +37.5% |
Q2 2020 | $855,000 | +44.9% | 253,052 | 0.0% | 0.01% | +14.3% |
Q1 2020 | $590,000 | -35.9% | 253,052 | 0.0% | 0.01% | +16.7% |
Q4 2019 | $921,000 | -61.2% | 253,052 | -11.7% | 0.01% | -62.5% |
Q3 2019 | $2,376,000 | +17.6% | 286,452 | +22.1% | 0.02% | 0.0% |
Q2 2019 | $2,020,000 | +102.4% | 234,600 | +151.2% | 0.02% | +77.8% |
Q1 2019 | $998,000 | +31.5% | 93,400 | +7.7% | 0.01% | +50.0% |
Q4 2018 | $759,000 | -34.1% | 86,700 | +26.6% | 0.01% | -25.0% |
Q3 2018 | $1,151,000 | -9.5% | 68,500 | +12.9% | 0.01% | -11.1% |
Q2 2018 | $1,272,000 | +35.0% | 60,676 | +3.6% | 0.01% | +28.6% |
Q1 2018 | $942,000 | -45.8% | 58,576 | -36.2% | 0.01% | -36.4% |
Q4 2017 | $1,739,000 | +162.7% | 91,776 | +95.0% | 0.01% | +266.7% |
Q3 2017 | $662,000 | +143.4% | 47,076 | +28.8% | 0.00% | +50.0% |
Q2 2017 | $272,000 | -16.0% | 36,550 | -26.7% | 0.00% | -33.3% |
Q1 2017 | $324,000 | +46.6% | 49,850 | 0.0% | 0.00% | +50.0% |
Q4 2016 | $221,000 | -5.2% | 49,850 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $233,000 | -13.1% | 49,850 | +22.0% | 0.00% | -33.3% |
Q2 2016 | $268,000 | +3.1% | 40,850 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $260,000 | +5.7% | 40,850 | 0.0% | 0.00% | +50.0% |
Q4 2015 | $246,000 | -36.9% | 40,850 | -37.4% | 0.00% | -33.3% |
Q3 2015 | $390,000 | -36.7% | 65,250 | -27.5% | 0.00% | -25.0% |
Q2 2015 | $616,000 | -7.1% | 90,050 | -17.5% | 0.00% | -20.0% |
Q1 2015 | $663,000 | -11.8% | 109,150 | +0.6% | 0.01% | 0.0% |
Q4 2014 | $752,000 | -14.8% | 108,476 | 0.0% | 0.01% | -16.7% |
Q3 2014 | $883,000 | -9.8% | 108,476 | -9.9% | 0.01% | 0.0% |
Q2 2014 | $979,000 | +12.8% | 120,376 | +8.8% | 0.01% | 0.0% |
Q1 2014 | $868,000 | -24.9% | 110,675 | -15.3% | 0.01% | -14.3% |
Q4 2013 | $1,156,000 | +7.7% | 130,675 | +2.2% | 0.01% | 0.0% |
Q3 2013 | $1,073,000 | +45.4% | 127,875 | +29.3% | 0.01% | +16.7% |
Q2 2013 | $738,000 | – | 98,875 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |